Sulodexide Completed Phase 2 Trials for Retinopathy, Diabetic Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01295775Diabetic Retinopathy Sulodexide Study